Find-A-Study

A Phase 2a, Open-label, Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-224 in Participants with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Purpose

Category

Heart, Vascular and Blood

IRB Number: 20220477HU
NCT Number: -
Sponsor: -

Study Contact

Principal Investigator
Allen Anderson

Dior Enriquez
210-450-7305
enriquezd1@uthscsa.edu

Johnnie Jones
210-450-7277
jonesj21@uthscsa.edu

Lorannys Sanchez Tamarez
210-450-3937
sancheztamar@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups